{"id":"https://openalex.org/W2046314938","doi":"https://doi.org/10.1080/10543409608835128","title":"Using the proportional odds model to assess the relationship between a multi-item and a global item efficacy scale in a psychiatric clinical trial","display_name":"Using the proportional odds model to assess the relationship between a multi-item and a global item efficacy scale in a psychiatric clinical trial","alternate_titles":[],"publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W2046314938","doi":"https://doi.org/10.1080/10543409608835128","mag":"2046314938","pmid":"https://pubmed.ncbi.nlm.nih.gov/8732909"},"language":"en","primary_location":{"id":"doi:10.1080/10543409608835128","doi":"https://doi.org/10.1080/10543409608835128","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10543409608835128","pdf_url":null,"source":{"id":"https://openalex.org/S56946555","display_name":"Journal of Biopharmaceutical Statistics","issn_l":"1054-3406","issn":["1054-3406","1520-5711"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Biopharmaceutical Statistics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2046314938"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109148006","display_name":"Roy Tamura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roy N. Tamura","raw_affiliation_strings":["a Statistical and Mathematical Sciences Lilly Research Laboratories , Eli Lilly and Company , Indianapolis, Indiana, 46285","Statistical and Mathematical Sciences Lilly Research Laboratories , Eli Lilly and Company , Indianapolis, Indiana, 46285"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a Statistical and Mathematical Sciences Lilly Research Laboratories , Eli Lilly and Company , Indianapolis, Indiana, 46285","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Statistical and Mathematical Sciences Lilly Research Laboratories , Eli Lilly and Company , Indianapolis, Indiana, 46285","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076494729","display_name":"Yoko Tanaka","orcid":"https://orcid.org/0000-0001-8315-1397","observed_orcids":["https://orcid.org/0000-0001-8315-1397"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yoko Tanaka","raw_affiliation_strings":["b Department of Statistics , University of Florida , Gainesville, Florida, 39203","Department of Statistics , University of Florida , Gainesville, Florida, 39203"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b Department of Statistics , University of Florida , Gainesville, Florida, 39203","institution_ids":["https://openalex.org/I33213144"]},{"raw_affiliation_string":"Department of Statistics , University of Florida , Gainesville, Florida, 39203","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006693273","display_name":"Katsuyoshi Satoh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108315","display_name":"Eli Lilly (Japan)","ror":"https://ror.org/01sv7f575","country_code":"JP","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210108315"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Katsuyoshi Satoh","raw_affiliation_strings":["c Information Systems and Services , Eli Lilly Japan K. K. , Chuo-ku, Kobe Japan, 651","Information Systems and Services , Eli Lilly Japan K. K. , Chuo-ku, Kobe Japan, 651"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"c Information Systems and Services , Eli Lilly Japan K. K. , Chuo-ku, Kobe Japan, 651","institution_ids":["https://openalex.org/I4210108315"]},{"raw_affiliation_string":"Information Systems and Services , Eli Lilly Japan K. K. , Chuo-ku, Kobe Japan, 651","institution_ids":["https://openalex.org/I4210108315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087349260","display_name":"Masashi Takahashi","orcid":"https://orcid.org/0000-0003-4603-5594","observed_orcids":["https://orcid.org/0000-0003-4603-5594"]},"institutions":[{"id":"https://openalex.org/I4210108315","display_name":"Eli Lilly (Japan)","ror":"https://ror.org/01sv7f575","country_code":"JP","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210108315"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masashi Takahashi","raw_affiliation_strings":["d Clinical Research , Eli Lilly Japan K. K. , Chuo-ku, Kobe Japan, 651","Clinical Research , Eli Lilly Japan K. K. , Chuo-ku, Kobe Japan, 651"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"d Clinical Research , Eli Lilly Japan K. K. , Chuo-ku, Kobe Japan, 651","institution_ids":["https://openalex.org/I4210108315"]},{"raw_affiliation_string":"Clinical Research , Eli Lilly Japan K. K. , Chuo-ku, Kobe Japan, 651","institution_ids":["https://openalex.org/I4210108315"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3403,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.52779673,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":"6","issue":"2","first_page":"127","last_page":"137"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10243","display_name":"Statistical Methods and Bayesian Inference","score":0.015300000086426735,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10467","display_name":"Psychometric Methodologies and Testing","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/1803","display_name":"Management Science and Operations Research"},"field":{"id":"https://openalex.org/fields/18","display_name":"Decision Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/proportional-odds-model","display_name":"proportional odds model","score":1.0},{"id":"https://openalex.org/keywords/ordinal-data","display_name":"ordinal data","score":0.6330000162124634},{"id":"https://openalex.org/keywords/multi-item-scales","display_name":"multi-item scales","score":0.5580000281333923},{"id":"https://openalex.org/keywords/global-rating-scale","display_name":"global rating scale","score":0.8840000033378601},{"id":"https://openalex.org/keywords/scale-relationships","display_name":"scale relationships","score":0.6140000224113464},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.7020000219345093},{"id":"https://openalex.org/keywords/psychiatric-clinical-trials","display_name":"psychiatric clinical trials","score":0.7279999852180481},{"id":"https://openalex.org/keywords/segmented-regression","display_name":"segmented regression","score":0.9039999842643738},{"id":"https://openalex.org/keywords/residual-analysis","display_name":"residual analysis","score":0.5239999890327454},{"id":"https://openalex.org/keywords/predicted-probabilities","display_name":"predicted probabilities","score":0.6679999828338623},{"id":"https://openalex.org/keywords/trial-planning","display_name":"trial planning","score":0.4059999883174896}],"concepts":[{"id":"https://openalex.org/C143095724","wikidata":"https://www.wikidata.org/wiki/Q515895","display_name":"Odds","level":3,"score":0.7736912965774536},{"id":"https://openalex.org/C85461838","wikidata":"https://www.wikidata.org/wiki/Q7100785","display_name":"Ordinal data","level":2,"score":0.7575244903564453},{"id":"https://openalex.org/C110313322","wikidata":"https://www.wikidata.org/wiki/Q7100793","display_name":"Ordinal regression","level":2,"score":0.6756348609924316},{"id":"https://openalex.org/C87227347","wikidata":"https://www.wikidata.org/wiki/Q7100713","display_name":"Ordered logit","level":2,"score":0.6735769510269165},{"id":"https://openalex.org/C2909711754","wikidata":"https://www.wikidata.org/wiki/Q7100785","display_name":"Ordinal Scale","level":2,"score":0.5694498419761658},{"id":"https://openalex.org/C163175372","wikidata":"https://www.wikidata.org/wiki/Q3339222","display_name":"Linear model","level":2,"score":0.5607391595840454},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.5595431923866272},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5133211016654968},{"id":"https://openalex.org/C149782125","wikidata":"https://www.wikidata.org/wiki/Q160039","display_name":"Econometrics","level":1,"score":0.5052242875099182},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.4726908504962921},{"id":"https://openalex.org/C2778755073","wikidata":"https://www.wikidata.org/wiki/Q10858537","display_name":"Scale (ratio)","level":2,"score":0.4548932909965515},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.4171587824821472},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3722827434539795},{"id":"https://openalex.org/C205649164","wikidata":"https://www.wikidata.org/wiki/Q1071","display_name":"Geography","level":0,"score":0.08366990089416504},{"id":"https://openalex.org/C58640448","wikidata":"https://www.wikidata.org/wiki/Q42515","display_name":"Cartography","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011570","descriptor_name":"Psychiatry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015337","descriptor_name":"Multicenter Studies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016014","descriptor_name":"Linear Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/10543409608835128","doi":"https://doi.org/10.1080/10543409608835128","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10543409608835128","pdf_url":null,"source":{"id":"https://openalex.org/S56946555","display_name":"Journal of Biopharmaceutical Statistics","issn_l":"1054-3406","issn":["1054-3406","1520-5711"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Biopharmaceutical Statistics","raw_type":"journal-article"},{"id":"pmid:8732909","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8732909","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of biopharmaceutical statistics","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8199999928474426,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W122505910","https://openalex.org/W214995755","https://openalex.org/W2002374079","https://openalex.org/W2004030282","https://openalex.org/W2013357899","https://openalex.org/W2020844317","https://openalex.org/W2150312268","https://openalex.org/W4236554388"],"related_works":["https://openalex.org/W4239252336","https://openalex.org/W7098340053","https://openalex.org/W4414497926","https://openalex.org/W264515357","https://openalex.org/W2166293159","https://openalex.org/W2039549173","https://openalex.org/W2522204911","https://openalex.org/W4382318317","https://openalex.org/W2354103526"],"abstract_inverted_index":{"The":[0,24,38],"proportional":[1,25,57],"odds":[2,26,58],"model":[3,27,62,67,101],"is":[4,51],"illustrated":[5],"in":[6,14],"the":[7,29,36,45,48,69,87,93,100,109],"analysis":[8,39],"of":[9,33,35,40,99,104,111],"two":[10,49],"efficacy":[11],"scales":[12,50],"used":[13],"a":[15,55,64],"phase":[16],"II":[17],"clinical":[18],"trial":[19],"involving":[20],"81":[21],"schizophrenic":[22],"patients.":[23],"preserves":[28],"discrete,":[30],"ordinal":[31,88],"nature":[32],"one":[34],"scales.":[37],"this":[41],"data":[42],"suggested":[43],"that":[44],"relationship":[46],"between":[47],"not":[52],"captured":[53],"by":[54],"linear":[56,61,66],"model.":[59,95],"A":[60],"and":[63,97,107],"piecewise":[65],"for":[68,86,102,108],"explanatory":[70],"variable":[71],"were":[72,82,90],"therefore":[73],"compared":[74],"using":[75],"likelihood-based":[76],"analyses.":[77],"Residuals":[78],"from":[79,92],"both":[80],"models":[81],"compared.":[83],"Predicted":[84],"probabilities":[85],"categories":[89],"constructed":[91],"estimated":[94],"Extensions":[96],"limitations":[98],"interpretation":[103],"other":[105],"trials":[106,113],"planning":[110],"future":[112],"are":[114],"discussed.":[115]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2046314938","counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}
